Replies to post #2379 on AVEO Pharmaceuticals, Inc. (AVEO)

[Full Contact Yoga]

Phase 3 is a long way off...company continues to disappoint, struggling to maintain $1 to maintain listing, very disappointing Q, weak leadership, likely RS proposal on the plate soon, again...very little to be happy about IMO, but might trade as it sets new lows...